EP10.01. Efficacy and Safety of Nintedanib and Docetaxel in Patients with Lung Adenocarcinoma: A Multicenter Real-world Analysis - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Marko Jakopovic
Meta Tag
Speaker Marko Jakopovic
Topic Metastatic NSCLC: Cytotoxic Therapy
Keywords
efficacy
safety
nintedanib
docetaxel
lung adenocarcinoma
progression-free survival
objective response
overall survival
chemotherapy
immune checkpoint inhibitor
Powered By